Prognostic significance of the endoscopic ultrasound defined lymph node metastasis count in esophageal cancer

Diseases of the Esophagus

Volumn 23, Issue 8, 2010, Pages 652-659

  Twine, C P ^a   Roberts, S A ^a   Rawlinson, C E ^a   Davies, L ^a   Escofet, X ^a   Dave, B V ^a   Crosby, T D ^b   Lewis, W G ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Endoscopic ultrasonography; Esophageal cancer; Lymph node metastasis; Prognosis

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ACCURACY; ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR VOLUME; UNITED KINGDOM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; PROGNOSIS; SURVIVAL RATE;

EID: 78649495798     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01072.x     Document Type: Article

References (29)

1. Kelly S, Harris K M, Berry E et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001; 49: 534-9.
2. Weaver S R, Blackshaw G R, Lewis W G et al. Comparison of special interest computed tomography, endosonography and histopathological stage of oesophageal cancer. Clin Radiol 2004; 59: 499-504.
3. Kawahara K, Maekawa T, Okabayashi K et al. The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol 1998; 67: 160-3.
4. Kodera Y, Yamamura Y, Shimizu Y et al. The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg 1998; 187: 597-603.
5. Natsugoe S, Yoshinaka H, Shimada M et al. Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma. Ann Surg 2001; 234: 613-8.
6. Peters C J, Hardwick R H, Vowler S L, Fitzgerald R C. Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg 2009; 96: 724-33.
7. Bowrey D, Clark G, Roberts S et al. Endosonographic staging of 100 consecutive patients with esophageal carcinoma: introduction of the 8-mm esophagoprobe. Dis Esophagus 1999; 12: 258-63.
8. Twine C P, Lewis W G, Escofet X, Bosanquet D, Ashley R S. Prospective comparison of optic versus blind endoscopic ultrasound in staging esophageal cancer. Surg Endosc 2009; May 14. [Epub ahead of print.
9. Twine C P, Ashley R S, Lewis W G et al. Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer. Surg Endosc 2010; 24: 870-8.
10. Eloubeidi M A, Desmond R, Arguedas M R, Reed C E, Wilcox C M. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002; 95: 1434-43.
11. Gu Y, Swisher S G, Ajani J A et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 2006; 106: 1017-25.
12. Korst R J, Rusch V W, Venkatraman E et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998; 115: 660-9.
13. Mariette C, Piessen G, Briez N, Triboulet J P. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 2008; 247: 365-71.
14. Rizk N, Venkatraman E, Park B, Flores R, Bains M S, Rusch V. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg 2006; 132: 1374-81.
15. Tachibana M, Yoshimura H, Kinugasa S et al. Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer. Dig Liver Dis 2001; 33: 534-8.
16. Stephens M R, Lewis W G, Brewster A E et al. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus 2006; 19: 164-71.
17. Orringer M B. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Ann Surg 1984; 200: 282-8.
18. Lewis I. The surgical treatment of carcinoma of the oesophagus, with special reference to a new operation for growths of the middle third. Br J Surg 1946; 51: 53-68.
19. Tanner I C. The present position of carcinoma of the oesophagus. Postgrad Med J 1947; 23: 109-39.
20. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. JASA 1958; 58: 457-81.
21. Landis J, Koch G G. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
22. Cox D R. Regression models and life tables. J R Statist Soc 1972; B: 187-200.
23. Morgan M A, Lewis W G, Hopper A N et al. Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus 2007; 20: 29-35.
24. Morgan M A, Lewis W G, Crosby T D et al. Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer. Br J Surg 2007; 94: 1509-14.
25. Morgan M A, Lewis W G, Hopper A N et al. Prospective comparison of transthoracic versus transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer. Dis Esophagus 2007; 20: 225-31.
26. Barbour A P, Rizk N, Gerdes H et al. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. J Am Coll Surg 2007; 205: 593-601.
27. Omloo J M, Lagarde S M, Hulscher J B et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007; 246: 992-1000.
28. Chen J, Xu R, Hunt G C, Krinsky M L, Savides T J. Influence of the number of malignant regional lymph nodes detected by endoscopic ultrasonography on survival stratification in esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2006; 4: 573-9.
29. Rest C C, Metges J P, Teyton P et al. Prognostic value of initial fluorodeoxyglucose-PET in esophageal cancer: a prospective study. Nucl Med Commun 2008; 29: 628-35.